The Cost Effectiveness of Adjunctive Treatments for Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease
Use of PPI-adjunctive therapies in those with persistent GERD symptoms may become cost effective when guided by ambulatory pH tests. These data can guide investigators, industry, and payers as they develop, validate, and price new treatments for PPI-refractory GERD.
Authors
- Brennan Spiegel (ORCID: https://orcid.org/0000-0002-4608-6896)
- Kyung‐Sang Yu (ORCID: https://orcid.org/0000-0003-0921-7225)
- Ulysses S. Rosas
- Christopher V. Almario (ORCID: https://orcid.org/0000-0003-0664-9479)
Institutions
- Cedars-Sinai Medical Center (US)
- UCLA Health (US)
- Sinai Health System (US)
Publication Details
- Journal
- Clinical Drug Investigation
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1007/s40261-024-01387-7
- Citations
- 1
- Primary Topic
- Gastroesophageal reflux and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.46
Funders
- Ironwood Pharmaceuticals, Incorporated
- Cedars-Sinai Medical Center